Pentisomide

This classification denotes an antiarrhythmic agent with the molecular formula C19H33N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 506T8KTW5Q, chemically known as 2-pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-(2-methylpropyl)-, (+-)- but more generally known as pentisomide, which bears US NIH Compound Identifier 65847. European Medicines Agency schedules Pentisomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09697MIG. The term PENTISOMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). PENTISOMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pentisomide under HS 29333999 and SITC 51574. As of Q4 2014, PENTISOMIDE remains US FDA's Preferred Term for this commodity. Pentisomide bears US NLM identifiers UMLS ID C0072206 and NCI Concept Code C90666. SMILES: O=C(N)C(CCN(C(C)C)C(C)C)(CC(C)C)C1NCCCC1.